These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 23690963)

  • 21. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
    Clancy C; Joyce MR; Kerin MJ
    Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma miRNA can detect colorectal cancer, but how early?
    Wikberg ML; Myte R; Palmqvist R; van Guelpen B; Ljuslinder I
    Cancer Med; 2018 May; 7(5):1697-1705. PubMed ID: 29573205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
    Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer.
    Faltejskova P; Bocanek O; Sachlova M; Svoboda M; Kiss I; Vyzula R; Slaby O
    Cancer Biomark; 2012; 12(4):199-204. PubMed ID: 23568010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a circulating microRNA signature for colorectal cancer detection.
    Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
    PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
    Yuan Z; Baker K; Redman MW; Wang L; Adams SV; Yu M; Dickinson B; Makar K; Ulrich N; Böhm J; Wurscher M; Westerhoff M; Medwell S; Moonka R; Sinanan M; Fichera A; Vickers K; Grady WM
    Br J Cancer; 2017 Oct; 117(8):1202-1210. PubMed ID: 28809863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a four-microRNA panel in serum as promising biomarker for colorectal carcinoma detection.
    Huang G; Wei B; Chen Z; Wang J; Zhao L; Peng X; Liu K; Lai Y; Ni L
    Biomark Med; 2020 Jun; 14(9):749-760. PubMed ID: 32672054
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
    Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
    PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
    Yong FL; Law CW; Wang CW
    BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
    Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
    Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.
    Zaki A; Fawzy A; Akel SY; Gamal H; Elshimy RAA
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):723-730. PubMed ID: 35225486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
    Wada Y; Shimada M; Murano T; Takamaru H; Morine Y; Ikemoto T; Saito Y; Balaguer F; Bujanda L; Pellise M; Kato K; Saito Y; Ikematsu H; Goel A
    Gastroenterology; 2021 Jul; 161(1):151-162.e1. PubMed ID: 33819484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
    Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients.
    Duran-Sanchon S; Vila-Navarro E; Marcuello M; Lozano JJ; Muñoz J; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; Herreros-Villanueva M; Martín AC; Pérez-Palacios R; Arroyo R; Castells A; Gironella M
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.